Inozyme Pharma (INZY) Earnings Date & Reports

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INZY is expected to report earnings to fall 17.18% to -36 cents per share on August 12

Inozyme Pharma INZY Stock Earnings Reports

Q2'25

Est.

$-0.36

Q1'25

Missed

by $0.04

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.05

Q2'24

Missed

by $0.04

The last earnings report on May 14 showed earnings per share of -43 cents, missing the estimate of -40 cents. With 386.44K shares outstanding, the current market capitalization sits at 258.25M.

View a ticker or compare two or three

Compare

INZY